🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Co-Founder & Chief Scientific Officer, Dr. Omer Inan, presented our approach to heart failure management which leverages wearable sensors and AI-driven algorithms designed to detect early signs of cardiac deterioration and improve patient outcomes HRX. #HRX2024

We're on a mission to transform heart failure management for the 6M+ Americans in need and democratize specialty care. Join us at #TCT2024 & @American_heart as we unveil groundbreaking study results on our AI-driven, non-invasive heart failure management platform. #Cardiology

Join us! Liviu Klein presents SEISMIC-HF I study results at #AHA2024 (Nov 16, 3:15 PM, LBS.03). Our #AI model non-invasively estimates cardiac filling pressure, aiming to transform #heartfailure management w/wearable sensors. See you there! #AHAChicago #AIinHealthcare

Will we see you at #AHA24? Our late-breaking science is on the big stage showcasing performance of our #AI model in non-invasively estimating cardiac filling pressure. Join us at 3:30 PM CT (LBS.03) to learn the latest about how we’re helping create the future of cardiac care.

Non-invasive measurement of PCWP using AI-based CardioTag device similar to invasive RHC numbers. Data encouraging for widespread hemodynamic-guided remote management of HF pts. Dr. Klein shares results of SEISMIC-HF study clinicaltrialresults.org/wp-content/upl…

AI-based non-invasive assessment of intracardiac filling pressures using CardioTag device accurately estimates PCWP in HFrEF patients, comparable to RHC measurements. Download slides from the SEISMIC-HF study clinicaltrialresults.org/wp-content/upl…

SEISMIC-HF I: 🔑 Algorithm in pts w HFrEF scheduled for right heart cath 🔑 Algorithm was able to estimate PCWP 🔑May help enable hemodynamic-guided mgmt in HF #AHA24 American Heart News American Heart Association #cardiotwitter

“These results provide an important step towards enabling widespread hemodynamic-guided remote management of HF patients,” said Liviu Klein #AHA24 tctmd.com/news/novel-ai-… Cardiosense

Our team is excited to attend #ACC25 in our hometown of #Chicago! We’re dedicated to transforming cardiovascular management with AI. Connect with us & learn how we're revolutionizing heart health! #Cardiology

Exciting news from #THT2025! The latest study validated the ability of our wearable sensor to noninvasively & accurately capture SCG, ECG & PPG signals to measure LVET, compared to echocardiography, opening new possibilities. Thx to all collaborators! #HeartFailure #WearableTech

Cardiosense CEO @AmitGupta will showcase AI-guided therapy for disease management during the Healthcare Entrepreneurship Forum hosted by the Kellogg School on April 25th. Register here & bookmark the “Reinventing Medtech with AI” panel with Amit🔗 eventbrite.com/e/kellogg-heal…

Celebrating 5 years of transforming cardiac care through #AI! From FDA breakthrough designation to AHA late-breaking science, we're working to bring smarter, personalized care to 6.7M Americans with heart failure. Thank you to our team, partners & patients who make it possible!

We’re proud to announce the launch of the nationwide SEISMIC-HF II study to validate our algorithm to assess intracardiac filling pressures. It’s a major step toward smarter, personalized cardiac care for all heart failure patients. Read more: cardiacvascularnews.com/cardiosense-la…

🗞️Just published in MedTech Strategist | MedTech's Most Trusted Source: Cardiosense CEO Amit Gupta shares how #AI is unlocking a comprehensive physiological picture of cardiac function for doctors. Smarter care starts with tracking what matters. Read the story (avail w/ subscription): mystrategist.com/medtech-strate…

Just published in the JACC Journals: Results from the 15-site SEISMIC-HF I study demonstrate the power of Cardiosense’s AI algorithm to noninvasively estimate cardiac filling pressures on par with implantable sensors. The full results in #JACCHF ▶️sciencedirect.com/science/articl…

➡️Clinical implications: continuous, outpatient PCWP tracking could revolutionize how we detect subtle hemodynamic derangements early—potentially reducing hospital visits, guiding meds, and improving outcomes in HF care.

Fewer than 1% of eligible HF patients receive implantable monitors. A new JACC:HF editorial highlights how CardioTag may change that—by reducing barriers, scaling access, and performing across diverse subgroups. Read the review: jacc.org/doi/10.1016/j.…

The Cardiosense Difference: Three Signals. One Actionable Picture of Heart Failure. See how our non-invasive technology is on a path to transform heart failure care and enable personalized heart failure management. Learn more in #JACCHF: loom.ly/O9AQ8Hg